CML,Blast Phase
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Modified Conditioning Regimen for CML-BP (NCT07259161) | Institute of Hematology & Blood Diseases Hospital, China | 2025-12-15 |
| Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML (NCT06757855) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-26 |
Track CML,Blast Phase automatically
Every clearance here is in the API, with alerts when new ones post.